Fresh Tracks Therapeutics, Inc. (FRTX)
OTCMKTS
· Delayed Price · Currency is USD
0.740
0.00 (0.00%)
Dec 24, 2024, 4:00 PM EST
Fresh Tracks Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 8.01 | 8.01 | 6.94 | 0.4 | 1.82 | 7.92 | Upgrade
|
| Revenue Growth (YoY) | 15.31% | 15.31% | 1618.56% | -77.83% | -76.99% | -27.29% | Upgrade
|
| Cost of Revenue | 3.18 | 3.18 | 14.04 | 28.23 | 11.22 | 20.21 | Upgrade
|
| Gross Profit | 4.82 | 4.82 | -7.1 | -27.83 | -9.39 | -12.3 | Upgrade
|
| Selling, General & Admin | 11.18 | 11.18 | 14.43 | 12.42 | 11.58 | 11.73 | Upgrade
|
| Operating Expenses | 11.18 | 11.18 | 14.43 | 12.42 | 11.58 | 11.73 | Upgrade
|
| Operating Income | -6.36 | -6.36 | -21.53 | -40.24 | -20.98 | -24.03 | Upgrade
|
| Interest Expense | -0.01 | -0.01 | -0.01 | -0.07 | - | -2.1 | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0.06 | 0.16 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.67 | 0.67 | 0.44 | 0.4 | - | 0.21 | Upgrade
|
| EBT Excluding Unusual Items | -5.69 | -5.69 | -21.1 | -39.91 | -20.91 | -25.75 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -0.44 | Upgrade
|
| Other Unusual Items | - | - | - | 0.44 | - | 2.32 | Upgrade
|
| Pretax Income | -5.69 | -5.69 | -21.1 | -39.47 | -20.91 | -23.88 | Upgrade
|
| Net Income | -5.69 | -5.69 | -21.1 | -39.47 | -20.91 | -23.88 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | -10.27 | Upgrade
|
| Net Income to Common | -5.69 | -5.69 | -21.1 | -39.47 | -20.91 | -13.6 | Upgrade
|
| Shares Outstanding (Basic) | 5 | 5 | 3 | 2 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 5 | 3 | 2 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 92.11% | 92.11% | 57.33% | 227.63% | 710.92% | 415.01% | Upgrade
|
| EPS (Basic) | -1.06 | -1.06 | -7.51 | -22.12 | -38.39 | -202.49 | Upgrade
|
| EPS (Diluted) | -1.06 | -1.06 | -7.51 | -22.12 | -38.39 | -202.49 | Upgrade
|
| Free Cash Flow | -4.34 | -4.34 | -19.38 | -36.18 | -20.06 | -35.99 | Upgrade
|
| Free Cash Flow Per Share | -0.81 | -0.81 | -6.90 | -20.27 | -36.82 | -535.71 | Upgrade
|
| Gross Margin | 60.25% | 60.25% | -102.26% | - | - | -155.32% | Upgrade
|
| Operating Margin | -79.44% | -79.44% | -310.15% | -9961.39% | -1151.26% | -303.49% | Upgrade
|
| Profit Margin | -71.12% | -71.12% | -303.93% | -9770.79% | -1147.80% | -171.82% | Upgrade
|
| Free Cash Flow Margin | -54.25% | -54.25% | -279.16% | -8956.44% | -1100.82% | -454.57% | Upgrade
|
| EBITDA | -6.32 | -6.32 | -21.5 | -40.22 | -20.97 | -24 | Upgrade
|
| EBITDA Margin | -78.93% | -78.93% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.04 | 0.04 | 0.03 | 0.02 | 0.01 | 0.03 | Upgrade
|
| EBIT | -6.36 | -6.36 | -21.53 | -40.24 | -20.98 | -24.03 | Upgrade
|
| EBIT Margin | -79.44% | -79.44% | - | - | - | - | Upgrade
|
| Revenue as Reported | 8.01 | 8.01 | 6.94 | 0.4 | 1.82 | 7.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.